Neutrophil to Lymphocyte Ratio: A Predictive Marker for Treatment Outcomes in Patients With Rectal Cancer Who Underwent Neoadjuvant Chemoradiation Followed by Surgery
- Author:
Byong Ho JEON
1
;
Ui Sup SHIN
;
Sun Mi MOON
;
Jung Il CHOI
;
Mi Sook KIM
;
Kie Hwan KIM
;
Se Jin SUNG
Author Information
- Publication Type:Original Article
- Keywords: Neutrophile lymphocyte ratio; Rectal neoplasms; Chemoradiotherapy; Biomarkers; Prognosis
- MeSH: Adenocarcinoma; Biomarkers; Chemoradiotherapy; Follow-Up Studies; Humans; Lymphocyte Count; Lymphocytes; Multivariate Analysis; Neutrophils; Odds Ratio; Polymerase Chain Reaction; Prognosis; Rectal Neoplasms; ROC Curve
- From:Annals of Coloproctology 2019;35(2):100-106
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: In this study, we investigated the role of neutrophil to lymphocyte ratio (NLR) as a predictor of tumor response and as a prognostic factor in patients with rectal cancer who had undergone curative surgery after neoadjuvant chemoradiation therapy (nCRT). METHODS: Between January 2009 and July 2016, we collected 140 consecutive patients who had undergone curative intent surgery after nCRT due to rectal adenocarcinoma. We obtained the pre- and post-nCRT NLR by dividing the neutrophil count by the lymphocyte count. The cutoff value was obtained using receiver operating characteristic analysis for tumor response and using maximally selected rank analysis for recurrence-free survival (RFS). The relationship among NLR, tumor response, and RFS was assessed by adjusting the possible clinico-pathological confounding factors. RESULTS: The possibility of pathologic complete response (pCR) was significantly decreased in high pre- (>2.77) and postnCRT NLR (>3.23) in univariate regression analysis. In multivariate analysis, high post-nCRT NLR was an independent negative predictive factor for pCR (adjusted odds ratio, 0.365; 95% confidence interval [CI], 0.145–0.918). The 5-year RFS of all patients was 74.6% during the median 37 months of follow-up. Patients with higher pre- (>2.66) and post-nCRT NLR (>5.21) showed lower 5-year RFS rates (53.1 vs. 83.3%, P = 0.006) (69.2 vs. 75.7%, P = 0.054). In multivariate Cox analysis, high pre-nCRT NLR was an independent poor prognostic factor for RFS (adjusted hazard ratio, 2.300; 95% CI, 1.061–4.985). CONCLUSION: Elevated NLR was a negative predictive marker for pCR and was independently associated with decreased RFS. For confirmation, a large-scale study with appropriate controls is needed.
